Target intelligence / Profile preview

Mitochondrial ribosomal protein L20 pseudogene 1 (MRPL20P1)

Target
MRPL20P1
Molecular classification
Other (pseudogene), related to ribosomal protein family
01

Overview

Mitochondrial ribosomal protein L20 pseudogene 1 (MRPL20P1) is a processed pseudogene related to the MRPL20 gene, which encodes the 39S ribosomal protein L20 in human mitochondria. MRPL20P1 is located on chromosome 21q and does not encode a functional ribosomal protein due to sequence changes such as mutated translation initiation codons. Pseudogenes like MRPL20P1 are generally considered noncoding genetic elements and do not produce functional proteins. While some pseudogenes elsewhere in the genome have been shown to influence gene regulation by acting as microRNA decoys or generating non-coding RNAs, there is no evidence that MRPL20P1 fulfills any such function in humans. MRPL20P1 is not implicated as a therapeutic target, nor is it associated with disease or biomarker utility. Its parent gene, MRPL20, is involved in the mitochondrial ribosome, but the pseudogene itself remains a nonfunctional genomic sequence.

Other names
mitochondrial ribosomal protein L20 pseudogene 1MRPL20 pseudogeneMRPL20P1
02

Mechanism of action

None applicable. No drugs target this pseudogene nor mechanistic studies on its modulation.

03

Biological functions

None established for MRPL20P1 specifically. In general, pseudogenes can sometimes act as decoys for microRNAs or participate in gene regulation, but no function for MRPL20P1 is known. Its parent gene, MRPL20, is involved in mitochondrial protein translation.
04

Disease associations

None for MRPL20P1. Its parent gene MRPL20 has associations with diseases, but no direct implication for MRPL20P1 is reported in disease etiology or pathology.
05

Safety considerations

None specific. There are no safety concerns or therapeutic challenges associated with targeting this pseudogene, as it is not targeted therapeutically.
06

Interacting drugs

None known. MRPL20P1 is not a molecular target for any approved or investigational drugs.
07

Biomarkers

None established. MRPL20P1 is not used as a biomarker for patient selection or efficacy monitoring.

Beyond the preview

Go deeper on Mitochondrial ribosomal protein L20 pseudogene 1 (MRPL20P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mitochondrial ribosomal protein L20 pseudogene 1 (MRPL20P1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call